Johnson & Johnson (NYSE:JNJ) today announced the U.S. Food and Drug Administration (FDA) approved DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) as a single agent treatment for adult patients ...
The drug thalidomide was withdrawn in 1961 after it was shown to have caused birth defects in thousands of children worldwide ...
HUNDREDS of birth defect victims will campaign for justice after their families were harmed by a drug given to pregnant women ...
Jennifer Bradley was told in 1970 that the DES drug prescribed during pregnancy was ‘completely safe’ - but it has left her ...